ChristopherRobertFlowersMD

PubMed

• 6 citations
  Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma.
  Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta
  Blood Advances. 2023-06-13
• 2 citations
  Herpes simplex virus lymphadenitis is associated with tumor reduction in a patient with chronic lymphocytic leukemia.
  Andres Chang, Anton M Sholukh, Andreas Wieland, David L Jaye, Mary Carrington
  The Journal of Clinical Investigation. 2022-09-15
• 29 citations
  Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma.
  Hua-Jay J Cherng, Ryan Sun, Bryant Sugg, Russell Irwin, Haopeng Yang
  Blood. 2022-08-04

Journal Articles

• Incidence and Outcomes of Lymphoid Malignancies in Adolescent and Young Adult Patients in the United States  
  Sharon Castellino, Frank G Keller, Christopher R Flowers, British Journal of Haematology

Abstracts/Posters

• A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes Following Early Relapse in Patients with Mantle Cell Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Polatuzumab Vedotin Plus Bendamustine with Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Updated Results of a Phase Ib/II Randomized Study
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Analysis of an Online Treatment Decision Tool Reveals Variances in Practice between Experts and Oncology Healthcare Providers for Newly Diagnosed Follicular Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Maintenance Rituximab Improves Outcomes in Mantle Cell Lymphoma Patients Who Respond to Induction Therapy with Bendamustine + Rituximab without Autologous Transplant
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Trial Participation Is Associated with Improved Overall Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Utility and Patterns of Use of PET/CT and Bone Marrow Biopsy for Staging in Non-Hodgkin Lymphoma in the Clinical Setting: A Retrospective Analysis Using the LEO Database
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival i...
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Data-Driven Approach to Define Parsimonious Eligibility Criteria in First-Line Clinical Trials for Diffuse Large B-Cell Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Consensus and Divergence in Practice Patterns Among Experts and Community Healthcare Providers for the Treatment of Patients with Mantle Cell Lymphoma
  Christopher R. Flowers, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Meeting Tips: Giving a Scientific Presentation, Being a Good Discussant and Asking a Question in the Aisle 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Promoting Minorities in Hematology Presentations and Reception 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Evaluation of Maintenance Therapy in Cutaneous T-Cell Lymphoma Patients Receiving Total Skin Electron Beam Radiation Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Genetic Analysis of Plasmablastic Lymphomas in HIV (+) Patients Reveals Novel Driver Regulators of the Noncanonical NF-Κb Pathway 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Polatuzumab Vedotin (Pola) Plus Bendamustine (B) with Rituximab (R) or Obinutuzumab (G) in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Updated Res... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• DLBCL Genomics 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• Join now to see all